Funded Startups in Rhone-Alpes
Among the 50 most recent disclosed rounds in Rhone-Alpes, Scintil Photonics’ $58M Series B (2025-09-14) is the only disclosed round above $50M, with the ne…
Among the 50 most recent disclosed rounds in Rhone-Alpes, Scintil Photonics’ $58M Series B (2025-09-14) is the only disclosed round above $50M, with the next-highest disclosed amounts landing far lower, including Osivax at $20M (2025-08-26) and MaaT Pharma at $44M (2025-07-28). The smallest disclosed amount in the set is $450K for DigitalKin (Pre-Seed, 2024-09-19), creating a wide disclosed-range tail from sub-$1M Seed/Pre-Seed rounds to a single $58M outlier.
Temporal and city clustering is also visible. Rounds run from 2024-06-04 (Sopht, Seed, $4M) through 2025-10-05 (TiHive Technologies, Series Unknown, $9M), with dense activity across mid-2025, including multiple July 2025 closings in and around Lyon and Grenoble. Sector-wise, Biotechnology is the most frequent label (appearing in 10 entries), and stage labeling skews heavily toward “Series Unknown” (18 entries) and “undisclosed” amounts (3 entries), which likely limits how many rounds can be compared strictly by disclosed deal size.
Most recent rounds
50 shownRelated listings
Frequently asked
What is the largest disclosed round in this Rhone-Alpes slice, and how isolated is it by deal size?
Scintil Photonics raised $58M on 2025-09-14 (Series B), making it the only disclosed round above $50M in the 50-row list. The next-largest disclosed figures are notably lower, such as MaaT Pharma’s $44M (2025-07-28) and Osivax’s $20M (2025-08-26), with many other rounds between roughly $1M and $27M.
Are the most recent rounds clustered in time, or spread evenly across the date range?
The rounds shown span from 2024-06-04 (Sopht, Seed, $4M) to 2025-10-05 (TiHive Technologies, Series Unknown, $9M). Activity concentrates in mid-2025: multiple deals close in July 2025 (e.g., STELLARIA on 2025-07-17 for $27M; BrainEver on 2025-07-03 for $39M; MaaT Pharma on 2025-07-28 for $44M), rather than distributing evenly month to month.
Do any sectors dominate, and how does that affect interpretability of the list?
Biotechnology is the most common sector label here, appearing in 10 of the 50 entries (e.g., Osivax $20M on 2025-08-26; MaaT Pharma $44M on 2025-07-28; BrainEver $39M on 2025-07-03). That concentration means cross-sector comparisons are sensitive to how deal sizes and stages differ across biotech versus the rest.
How much of the dataset lacks a usable disclosed amount, and does that create outlier risk?
There are 3 entries with an “undisclosed” amount (including N2F on 2025-06-03; Microoled on 2024-11-21; and Lium on 2024-11-08), which prevents sizing those rounds relative to disclosed peers. Separately, 18 entries carry “Series Unknown” (e.g., TiHive Technologies at $9M on 2025-10-05; Osivax at $20M on 2025-08-26), limiting stage-based ratio comparisons.
Which geography shows up repeatedly within the top 50, suggesting a local hub effect?
Lyon appears frequently across both high- and mid-sized rounds, including Osivax (Lyon, $20M on 2025-08-26), MaaT Pharma (Lyon, $44M on 2025-07-28), Adocia (Lyon, $10M on 2025-02-26), and Liberlo (Lyon, $2M on 2024-11-06). Grenoble and nearby cities also recur (e.g., TiHive Technologies in Grenoble, $9M on 2025-10-05; Scintil Photonics in Grenoble, $58M on 2025-09-14; plus multiple Grenoble-area entries like Saint-antonine and Montbonnot).
What stage mix looks most common among disclosed rounds, and are there stage-size extremes?
“Series Unknown” is the single largest stage category by count (18 entries), and it spans both smaller disclosed checks (e.g., AFYREN at $5M on 2025-07-08) and larger ones (e.g., Scintil Photonics is labeled Series B at $58M, but many other high figures like MaaT Pharma $44M are also Series Unknown). The most extreme disclosed deal size is the $58M Series B by Scintil Photonics (2025-09-14), while the smallest disclosed amount is $450K for DigitalKin (Pre-Seed, 2024-09-19).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.